Finerenone & psoriasis
Published: 15 June 2026| Version 1 | DOI: 10.17632/f4hm9k4ph3.1
Contributors:
Kuang-Hsi Chang, , , , I-Ju Tsai, Cheng-Li Lin, Der-Yang ChoDescription
Baseline characteristics of patients with type 2 diabetes and chronic kidney disease, stratified by Finerenone use.
Files
Steps to reproduce
This dataset contains the supplemental material associated with the manuscript entitled “Finerenone Use and Incident Psoriasis in Patients With Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study Using the TriNetX Network.”
Institutions
- Asia UniversityTaiwan, Taichung
Categories
Endocrinology, Epidemiology, Psoriasis
Funders
- Ministry of Health and WelfareGovernment of the Republic of ChinaTaipeiGrant ID: MOHW113-TDU-B-212-114009
- China Medical University HospitalTaichungGrant ID: DMR-111-105; DMR-112-087; DMR-113-009; DMR-113-156; DMR-114-046; DMR-114-139